3rd Quarter - Report

CAPITOL LEGISLATIVE STRATEGIES LLC for EMERGENT BIOSOLUTIONS INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

HR 2892, S 1298: Homeland Security Appropriations Act for Fiscal Year 2010 - Biodefense Vaccines; matters pertaining to the BioShield Project S. 3607: Department of Homeland Security Appropriations Act, 2011 - Biodefense Vaccines; matters pertaining to the BioShield Project

LobbyistCovered position, as disclosed
CHARLES J MELLODY Assistant to Chairman, House Ways and Means

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2892 (111th), S. 3607 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.